Reuters  Mar 9  Comment 
ARYx Therapeutics Inc said it would wind down its operations due to lack of funding after the U.S. health regulator delayed providing guidance on the trial design of the company's...
StreetInsider.com  Mar 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/ARYx+%28ARYX%29+Says+FDA+Issued+Prelim.+Notification+of+Additional+Delay+for+SPA+on+Naronapride%3B+Co.+Can+No+Longer+Continue+Operations/6357467.html for the full story.
MarketWatch  Mar 9  Comment 
Shares of Glaxo rise after a lupus treatment the company is set to market is approved by the U.S. Food and Drug Administration. Biotech firm ARYx says it’s ceasing operations.
Penny Stock DD  Dec 28  Comment 
ARYx Therapeutics, Inc. (NASDAQ: ARYX) jumped up by 33.33% and closed at $0.28 whereas overall traded volume stood at 2.41 million shares for the day. The current market price is 25.61% less than its last 50 days simple moving average. Repros...
StreetInsider.com  Dec 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ARYx+Therapeutics+%28ARYX%29+Updates+on+NASDAQ+Listing/6182562.html for the full story.
StreetInsider.com  Dec 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ARYx+Therapeutics+%28ARYX%29+To+Begin+Trading+on+NASDAQ+Capital+Market/6175513.html for the full story.
StreetInsider.com  Nov 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/ARYx+Therapeutics+%28ARYX%29+Posts+Q3+Loss+of+8c%2C+Narrower+than+Views/6103960.html for the full story.
StreetInsider.com  Aug 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ARYx+Therapeutics+%28ARYX%29+Announces+%246.3M+in+New+Financings/5897334.html for the full story.
StreetInsider.com  May 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/ARYx+Therapeutics+%28ARYX%29+Files+%2450M+Mixed+Shelf/5660920.html for the full story.
StreetInsider.com  May 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/ARYx+Therapeutics%2C+Inc.+%28ARYX%29+Posts+Q1+adj.-Loss+of+%240.18%2C+Shy+of+Views/5630154.html for the full story.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki